G20.A1

🧬 ICD-10-CM G20.A1 — Parkinson’s Disease Without Dyskinesia, Without Mention of Fluctuations

Billable Code Confirmed

ICD-10-CM G20.A1 is a valid, billable 5-character alphanumeric ICD-10-CM code for FY2026. All five characters are present: G20 (category — Parkinson’s Disease) + .A (without dyskinesia) + 1 (without mention of fluctuations/OFF episodes). No 7th character is required. This code was introduced effective October 1, 2023 (FY2024) as part of the G20 subcategory expansion — the prior single code G20 (Parkinson’s disease) was retired and replaced by the five-code specificity structure (G20.A1, G20.A2, G20.B1, G20.B2, G20.C1).

Non-Billable Parent Codes — Never Submit These

• ❌ G20 — The original 3-character code — retired as of FY2024; no longer a valid standalone submission
• ❌ G20.A — 4-character header — non-billable; missing fluctuation specifier
• ❌ G20.B — 4-character header — non-billable; missing fluctuation specifier

Always submit G20.A1 (all 5 characters) when Parkinson’s disease without dyskinesia AND without motor fluctuations or OFF episodes is documented. Submitting the retired bare G20 code will generate a coding specificity error for dates of service on or after October 1, 2023.

Clinical Context: Dyskinesia vs. Fluctuations — The Critical Distinction

G20.A1 requires understanding of TWO distinct motor complication dimensions that define the G20 subcategory structure:

• Dyskinesia — involuntary, purposeless writhing or choreiform movements that are a side effect of dopaminergic therapy (primarily levodopa); present = G20.B; absent = G20.A
• Fluctuations (OFF episodes) — periods when medication effect wears off or fails to fully activate, producing return of Parkinson’s motor symptoms (tremor, rigidity, bradykinesia); present = x2; without mention = x1

G20.A1 = no dyskinesia + no documented fluctuations = the stable, early-to-mid motor phase before levodopa motor complications develop.

Code Classification

ICD-10-CM Diagnosis Code — Etiology code; G20.A1 is an etiology code that sequences FIRST when dementia is also coded — the F02.x dementia codes are mandatory manifestation codes that sequence second behind G20.A1 per the etiology/manifestation convention. For associated inpatient procedure coding, see the ICD-10-PCS Crosswalk section below.

---

🔍 Code Description

ICD-10-CM G20.A1 classifies idiopathic Parkinson’s disease — the primary neurodegenerative movement disorder caused by progressive loss of dopaminergic neurons in the substantia nigra pars compacta — specifically in the stage characterized by the absence of levodopa-induced dyskinesia AND without documented motor fluctuations (OFF episodes).

Parkinson’s disease is defined by its cardinal motor tetrad: tremor at rest (classically a 4-6 Hz “pill-rolling” tremor in the hands that diminishes with intentional movement), rigidity (cogwheel or lead-pipe increase in tone throughout the passive range of motion), bradykinesia (slowness of movement, reduced amplitude, decrement on repetitive tasks), and postural instability (impaired balance reflexes leading to falls — typically a later feature). The clinical diagnosis of Parkinson’s disease requires bradykinesia plus at least one of rest tremor or rigidity, in the absence of features suggesting a Parkinson-plus syndrome (supranuclear gaze palsy → PSP; autonomic predominance → MSA; alien limb → corticobasal degeneration) or secondary/drug-induced causes.

The G20.A1 motor stage — without dyskinesia and without fluctuations — represents the earliest to middle phase of pharmacologically treated Parkinson’s disease where levodopa and/or dopamine agonist therapy provides a sustained, consistent therapeutic response throughout the day. In this phase, patients experience reliable ON time without the complication of dyskinesia (excess involuntary movements from medication) or wearing-off (predictable return of motor symptoms before the next dose). This represents the most favorable motor phase of treated Parkinson’s disease and is typical of the first several years following levodopa initiation.

---

🌳 Code Tree / Hierarchy

G20-G26 Extrapyramidal and Movement Disorders  
│  
├── G20 — Parkinson's Disease ❌ Non-billable (retired as of FY2024)  
│ │ [Excludes1: dementia with Parkinsonism (G31.83)]  
│ │ [Use additional code for dementia]  
│ │  
│ ├── G20.A — PD Without Dyskinesia ❌ Non-billable header  
│ │ ├── G20.A1 — Without dyskinesia, WITHOUT mention of fluctuations ◀ THIS CODE ✅ Billable  
│ │ │ [= No levodopa-induced dyskinesia; no OFF episodes; stable motor response]  
│ │ └── G20.A2 — Without dyskinesia, WITH fluctuations ✅ Billable  
│ │ [= No dyskinesia but wearing-off/OFF episodes present]  
│ │  
│ ├── G20.B — PD With Dyskinesia ❌ Non-billable header  
│ │ ├── G20.B1 — With dyskinesia, WITHOUT mention of fluctuations ✅ Billable  
│ │ │ [= Dyskinesia present but no wearing-off/OFF episodes]  
│ │ └── G20.B2 — With dyskinesia, WITH fluctuations ✅ Billable  
│ │ [= Both dyskinesia AND wearing-off/OFF episodes — most advanced motor complication stage]  
│ │  
│ └── G20.C — Parkinsonism, unspecified ✅ Billable  
│ [Use ONLY when idiopathic vs. secondary cannot be determined — not a default for underdocumented PD]  
│  
├── G21 — Secondary Parkinsonism ← EXCLUDES1 from G20 — entirely separate code family  
│ ├── G21.11 — Neuroleptic induced Parkinsonism  
│ ├── G21.19 — Other drug induced secondary Parkinsonism  
│ ├── G21.2 — Secondary Parkinsonism due to other external agents  
│ ├── G21.3 — Postencephalitic Parkinsonism  
│ ├── G21.4 — Vascular Parkinsonism  
│ ├── G21.8 — Other secondary Parkinsonism  
│ └── G21.9 — Secondary Parkinsonism, unspecified  
│  
└── G22 — Parkinsonism in diseases classified elsewhere ← Use with underlying disease code

Upgrade Specificity When Documented

G20.A1 is the correct code only when the physician documents — or the clinical record clearly reflects — absence of dyskinesia AND absence of motor fluctuations. As the disease progresses and motor complications develop, the correct code changes:

• Wearing-off appears, no dyskinesia yet → upgrade to G20.A2
• Dyskinesia appears, no wearing-off yet → upgrade to G20.B1
• Both dyskinesia AND wearing-off → upgrade to G20.B2

Never default to G20.A1 when the clinical record describes motor fluctuations or dyskinesia — that constitutes undercoding of motor complication severity.

---

✅ Includes

The following clinical terms and scenarios map to G20.A1 when idiopathic Parkinson’s disease is confirmed without dyskinesia and without documented OFF episodes or wearing-off:

• Idiopathic Parkinson’s disease without dyskinesia, without mention of OFF episodes
• Primary Parkinsonism without levodopa-induced dyskinesia, no motor fluctuations
• Parkinson’s disease, honeymoon phase (early dopaminergic therapy, stable response)
• Parkinson’s disease, well-controlled on levodopa/dopamine agonist, no motor complications
• Parkinson’s disease without mention of dyskinesia, without mention of wearing-off phenomena

---

❌ Excludes

Excludes 1 — Cannot Be Coded Simultaneously with G20.A1

Code	Description	Note
G21.11	Neuroleptic induced Parkinsonism	Mutually exclusive — drug-induced parkinsonism (from antipsychotics, metoclopramide, prochlorperazine) is not idiopathic PD; requires G21.11 + adverse effect T-code; CANNOT coexist with G20.A1
G21.19	Other drug induced secondary Parkinsonism	Mutually exclusive — secondary drug-induced parkinsonism; code additionally the adverse effect T-code for the causative drug
G21.2	Secondary Parkinsonism due to other external agents	Mutually exclusive — toxin-induced, MPTP-induced, manganese-induced Parkinsonism
G21.3	Postencephalitic Parkinsonism	Mutually exclusive — post-encephalitic cause
G21.4	Vascular Parkinsonism	Mutually exclusive — white matter disease-related parkinsonism
G21.8	Other secondary Parkinsonism	Mutually exclusive — all secondary forms
G21.9	Secondary Parkinsonism, unspecified	Mutually exclusive

Excludes 1 — Drug-Induced vs. Idiopathic Distinction Is Critical

The most clinically consequential Excludes 1 boundary for G20.A1 is G21.11 (neuroleptic-induced parkinsonism) and G21.19 (other drug-induced secondary parkinsonism). Parkinson’s symptoms induced by dopamine-blocking drugs (haloperidol, risperidone, metoclopramide) are NOT idiopathic Parkinson’s disease and must NEVER receive a G20.x code. The distinction requires physician documentation of idiopathic vs. drug-induced etiology — a CDI query is mandatory when a patient is on dopamine-blocking medications and parkinsonism is coded.

Excludes 2 — May Be Coded in Addition if Separately Present

Code	Description	Note
G31.83	Dementia with Lewy bodies	Excludes 2 from G20 category — Lewy body dementia is a separate entity from Parkinson’s dementia; may be coded alongside G20.A1 if both are distinctly documented; however, the clinical distinction between Parkinson’s disease dementia and DLB is a physician determination

Dementia with Lewy Bodies vs. Parkinson's Disease Dementia

G31.83 (dementia with Lewy bodies / DLB) is Excludes 2 from G20, meaning both may be coded if separately and distinctly documented. The clinical distinction: DLB presents with dementia first (or within 1 year of kicker parkinsonism), plus core features of fluctuating cognition, recurrent visual hallucinations, and REM sleep behavior disorder. Parkinson’s disease dementia (PDD, coded G20.A1 + F02.8x) occurs when established motor PD precedes dementia onset by more than 1 year (“1-year rule”). The physician must document which entity is present — coders cannot make this determination independently.

---

📋 Clinical Overview

The Two Motor Complication Axes — Defining G20 Subcategories

The 2023 G20 expansion created a 2×2 matrix based on two independent motor complication dimensions that emerge with long-term dopaminergic therapy. Understanding both axes is essential to accurate subcode selection.

Axis	Definition	Absent Code	Present Code
Dyskinesia	Involuntary, purposeless choreiform or writhing movements caused by peak-dose or diphasic levodopa effect; a pharmacological complication of long-term dopaminergic therapy	G20.A (no dyskinesia)	G20.B (dyskinesia present)
Fluctuations / OFF episodes	Periods of wearing-off — predictable return of PD motor symptoms (tremor, rigidity, bradykinesia) before the next dose — or unpredictable ON-OFF switching; a pharmacokinetic/pharmacodynamic complication of long-term levodopa	x1 (without fluctuations)	x2 (with fluctuations)

CDI Query Trigger — Motor Complications

If the treating neurologist documents only “Parkinson’s disease” or uses the retired bare code G20 without specifying dyskinesia/fluctuation status, a CDI query is warranted asking: “Does this patient have levodopa-induced dyskinesia?” and “Does this patient experience wearing-off or OFF episodes between doses?” The answers directly determine which of the four billable G20 subcodes is accurate — and the distinction is clinically meaningful for DRG accuracy, treatment planning, and DBS candidacy assessment.

Pathophysiology

Parkinson’s disease results from the selective, progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) — the midbrain nucleus that provides dopaminergic input via the nigrostriatal pathway to the striatum (caudate + putamen). Loss of approximately 60-80% of nigral dopamine neurons is required before motor symptoms become clinically apparent, which means a prolonged prodromal phase — characterized by non-motor features including REM sleep behavior disorder (RBD), anosmia, constipation, and autonomic dysfunction — precedes motor diagnosis by years to decades. The neuropathological hallmark is the Lewy body — an intraneuronal inclusion containing misfolded α-synuclein protein — which spreads in a caudal-to-rostral pattern consistent with Braak staging, progressing from dorsal vagal nucleus and olfactory bulb (Braak 1-2), through SNpc (Braak 3-4, onset of motor symptoms), to cortex (Braak 5-6, dementia and neuropsychiatric features).

The G20.A1 stage (without dyskinesia, without fluctuations) corresponds clinically to the phase when exogenous dopamine replacement — primarily levodopa/carbidopa — successfully restores striatal dopamine tone and produces a reliable, sustained therapeutic response. The remaining dopaminergic terminals have sufficient buffering capacity to store, release, and regulate exogenous levodopa in a pulsatile-to-tonic fashion that approximates physiological dopamine signaling. As the disease progresses and dopaminergic terminal loss becomes more severe, this buffering capacity diminishes — levodopa’s therapeutic window narrows, producing predictable wearing-off (→ G20.A2), then dyskinesia from receptor hypersensitization (→ G20.B1/G20.B2).

Clinical Presentation

Patients at the G20.A1 stage typically present with one or more of the following:

• Rest tremor — unilateral or bilateral 4-6 Hz rhythmic tremor, most prominent at rest, reduced with intentional movement; classic “pill-rolling” between thumb and index finger
• Rigidity — increased resistance to passive limb movement, either “cogwheel” (superimposed tremor on rigidity, felt as ratchet-like catches) or “lead-pipe” (uniform, sustained resistance without catches)
• Bradykinesia — slowness and reduced amplitude of repetitive movements; manifest as micrographia, hypophonia, masked facies (hypomimia), reduced arm swing during gait, shuffling gait with short steps
• Postural instability — typically a LATER feature in idiopathic PD (its early appearance should prompt reconsideration of Parkinson-plus syndrome)
• Non-motor features — constipation, orthostatic hypotension, anosmia, hyposmia, seborrhea, depression, anxiety, fatigue, REM sleep behavior disorder, urinary urgency

Documentation Requirements

For accurate assignment of G20.A1, physician documentation should include:

1. Explicit Parkinson’s disease diagnosis — “Parkinson’s disease,” “idiopathic Parkinson’s disease,” or “PD” — documented by the treating physician (neurologist or appropriately trained internist/geriatrician)
2. Confirmation of idiopathic etiology — absence of secondary cause (drug-induced, vascular, post-encephalitic); relevant when patient is on dopamine-blocking agents
3. Absence of dyskinesia — no documentation of involuntary choreiform/writhing movements attributable to dopaminergic therapy
4. Absence of fluctuations/OFF episodes — no documented wearing-off, predictable return of motor symptoms between doses, or unpredictable ON-OFF switching
5. Dementia status — if dementia is present, severity and behavioral disturbance type should be documented to enable the appropriate F02.x code pair; this is a mandatory “Use additional code” instruction under G20

---

💰 HCC Risk Adjustment (CMS-HCC v28)

Field	Detail
CMS-HCC Model Version	v28 (100% Implementation FY2026)
HCC Assignment	✅ Mapped — HCC 155
HCC Category Name	Parkinson’s Disease and Huntington’s Disease
RAF Coefficient (Community Non-Dual Aged)	~0.372
G20 Subcode Differentiation	All G20.A1, G20.A2, G20.B1, G20.B2 map to same HCC 155 — motor complication subcode does not differentiate HCC tier
RxHCC Assignment	Review current RxHCC mapping tables

G20.A1 maps to CMS-HCC v28 HCC 155 (Parkinson’s Disease and Huntington’s Disease), contributing a RAF coefficient of approximately 0.372 for community non-dual aged beneficiaries. All four idiopathic PD subcodes (G20.A1/A2/B1/B2) map to the same HCC tier — so the motor complication subcode selection does not affect RAF, but clinical documentation integrity and coding specificity accuracy remain mandatory compliance requirements.

Compound HCC Opportunities at Every G20.A1 Encounter

While G20.A1 itself provides HCC 155 RAF credit, multiple high-value comorbidities commonly present in Parkinson’s disease patients carry additional independent HCC weight that must be captured at every encounter:

• Parkinson’s disease dementia (F02.80, F02.A0, F02.B0, F02.C0 and disturbance variants) → HCC 125/126/127 by severity — a separate, stacked HCC requiring a physician query for dementia severity documentation
• Major depressive disorder (F32.x, F33.x) → review HCC mapping — highly prevalent in PD
• Dysphagia (R13.10-R13.19) → review HCC mapping — critical safety and care management code
• Orthostatic hypotension (G90.3) → review HCC mapping — autonomic dysfunction in PD
• Malnutrition — review for HCC mapping; prevalent in advanced PD with dysphagia
• Falls/fractures — code relevant injury codes when documented

All conditions meeting UHDDS “other diagnoses” criteria must be reported. Parkinson’s patients often carry 5-8 active conditions — complete capture is essential for accurate risk adjustment.

---

🏥 MS-DRG Assignment

MDC 01 — Diseases and Disorders of the Nervous System

DRG	Title	Est. Relative Weight*
DRG 056	Degenerative Nervous System Disorders with MCC	~2.23
DRG 057	Degenerative Nervous System Disorders without MCC	~1.30

*Approximate. Verify against IPPS FY2026 Final Rule tables. Note: Unlike most MDC 01 DRG triplets, degenerative nervous system disorders have only TWO DRGs (056/057) — there is no DRG 058 for this pair.

DRG 056 vs. 057 — The MCC Distinction Is High Impact

The weight differential between DRG 056 (~2.23) and DRG 057 (~1.30) is substantial — accurate identification and coding of MCCs is critical for appropriate reimbursement. Common Parkinson’s disease-associated MCCs include:

• Severe dementia coded to the F02.Cx severity tier (e.g., F02.C0) — if dementia severity is documented as severe, it qualifies as MCC and tips the case to DRG 056
• Aspiration pneumonia (J69.0) — a frequent complication of PD dysphagia; MCC
• Acute respiratory failure (J96.01) — MCC
• Sepsis (A41.9) — MCC
• Malnutrition (E41, E43, E44.0) — review MCC status

Always query the physician to document dementia severity, swallowing dysfunction, and nutritional status in every Parkinson’s disease inpatient encounter — the DRG 056 vs. 057 differentiation is almost entirely dependent on these frequently undercoded comorbidities.

---

🔗 Related ICD-10-CM Codes

G20 Subcode Variants — The Full Parkinson’s Motor Complication Matrix

Code	Description	Motor Stage
G20.A1	Without dyskinesia, without mention of fluctuations ← This Code	Early/stable; no motor complications
G20.A2	Without dyskinesia, with fluctuations	Wearing-off present; no dyskinesia yet
G20.B1	With dyskinesia, without mention of fluctuations	Dyskinesia present; no wearing-off
G20.B2	With dyskinesia, with fluctuations	Both complications present — most advanced
G20.C1	Parkinsonism, unspecified	Use only when idiopathic vs. secondary undetermined

Secondary Parkinsonism — Excludes1 from G20 (Separate Code Family)

Code	Description
G21.11	Neuroleptic induced Parkinsonism (antipsychotic-induced; code additionally adverse effect T-code)
G21.19	Other drug induced secondary Parkinsonism (metoclopramide, prochlorperazine, etc.)
G21.3	Postencephalitic Parkinsonism
G21.4	Vascular Parkinsonism

Mandatory Associated Codes — Dementia (Use Additional Code per Tabular Instruction)

Code	Description	HCC v28
F02.80	Dementia in other diseases, unspecified severity, without disturbance	HCC 127
F02.A0	Dementia in other diseases, mild, without disturbance	HCC 127
F02.B0	Dementia in other diseases, moderate, without disturbance	HCC 126
F02.C0	Dementia in other diseases, severe, without disturbance	HCC 125
F02.81	Dementia in other diseases, unspecified severity, with behavioral disturbance	HCC 127
F02.B1	Dementia in other diseases, moderate, with behavioral disturbance	HCC 126
F02.C1	Dementia in other diseases, severe, with behavioral disturbance	HCC 125

Common Parkinson’s Disease Comorbidity Codes

Code	Description	Coding Relevance
G90.3	Multi-system degeneration of the autonomic nervous system	Autonomic dysfunction in PD — orthostatic hypotension, neurogenic bladder, constipation; code additionally when documented
R13.19	Other dysphagia	Parkinson’s-related dysphagia — critical safety code; drives aspiration precautions, SLP consult, PEG tube discussion; code additionally when documented
J69.0	Pneumonitis due to inhalation of food and vomit (aspiration pneumonia)	Leading cause of death in advanced PD; MCC; code when aspiration pneumonia is documented
G47.52	REM sleep behavior disorder	Prodromal/concurrent PD feature; important for staging and counseling
R26.0	Ataxic gait	Gait disturbance in PD — code additionally when documented as affecting management
W19.XXXA	Unspecified fall, initial encounter	Fall associated with PD postural instability — code when fall occurs
F32.9	Major depressive disorder, single episode, unspecified	Highly prevalent neuropsychiatric comorbidity in PD — code additionally when documented
G31.83	Dementia with Lewy bodies	Excludes 2 from G20 — may coexist if physician documents DLB separately from PDD; see clinical distinction above

---

🛠️ Commonly Associated CPT Codes (Neurology)

Outpatient and Physician Setting Context

The CPT codes below are associated with the evaluation, management, and interventional treatment of Parkinson’s disease in outpatient and physician fee schedule settings. In the inpatient setting, ICD-10-PCS procedure codes govern procedural reporting.

CPT Code	Description	Clinical Application
99213	Office or other outpatient visit, established patient, low MDC	Routine stable Parkinson’s disease follow-up — medication refills, minor symptom review; ensure medical decision-making complexity supports level
99214	Office or other outpatient visit, established patient, moderate MDC	Parkinson’s disease follow-up with medication adjustment, complication management, or new symptom evaluation; the most common E/M level for PD neurology visits
99215	Office or other outpatient visit, established patient, high MDC	Complex Parkinson’s disease management — polypharmacy adjustment, motor complication workup, fall risk assessment with multiple comorbidities, DBS candidacy evaluation
99483	Cognitive assessment and care plan services	Annual cognitive assessment for Parkinson’s disease dementia screening or established PDD management; all 9 elements required; cannot be billed same DOS as standard E/M without modifier -25
96132	Neuropsychological testing evaluation; first hour	Formal neuropsychological battery for PD dementia staging, PDD vs. DLB differentiation, DBS candidacy cognitive evaluation
96133	+Neuropsychological testing evaluation; each additional hour	Add-on; never alone
96116	Neurobehavioral status exam; first hour	Office-based structured cognitive assessment — UPDRS cognitive subscale, MoCA, MMSE interpretation
95983	Electronic analysis of implanted neurostimulator pulse generator/transmitter (e.g., DBS), programming; first 15 minutes	DBS system programming session — analysis of neurostimulator parameters, lead impedance check, stimulation parameter adjustment; for established DBS patients with G20.A1 through G20.B2; requires in-person or telehealth interaction
95984	+Electronic analysis of implanted neurostimulator pulse generator/transmitter (e.g., DBS), programming; each additional 15 minutes	Add-on for each additional 15-minute block of DBS programming beyond the first; never alone
61885	Insertion or replacement of cranial neurostimulator pulse generator or receiver, direct or inductive coupling; with connection to a single electrode array	DBS internal pulse generator (IPG) implantation or replacement (battery change) — separately billable surgical procedure; G20.A1-G20.B2 support medical necessity
61886	Insertion or replacement of cranial neurostimulator pulse generator or receiver; with connection to two or more electrode arrays	Bilateral DBS IPG implantation — most common DBS configuration for Parkinson’s disease (bilateral STN or GPi)

NCCI Bundling Considerations

NCCI PTP Edits — Verify Before Billing

• 95983 and 95984 are time-based programming codes: 95983 covers the first 15 minutes; each 95984 add-on covers an additional 15 minutes. These cannot be billed on the same date as DBS lead implant (61867/61868) or IPG implant/replacement (61885/61886) — intraoperative programming is bundled into the surgical procedure codes.
• 99483 (cognitive assessment) and a same-day E/M (99214/99215): Modifier -25 must be appended to the E/M when both are performed on the same date and the E/M is separately documentable beyond the dementia/cognitive assessment itself.
• 96132 (neuropsychological testing) and 95983 (DBS programming) same DOS: these represent two distinct service types — verify there is no NCCI PTP edit and that documentation clearly supports each service as separate and medically necessary.
• 99214 or 99215 on the same DOS as 95983/95984: Modifier -25 must be appended to the E/M when the E/M is a significant, separately identifiable service beyond the DBS programming visit itself.

---

🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)

When G20.A1 is an inpatient diagnosis and a surgical or therapeutic procedure is performed, the following ICD-10-PCS sections and root operations are relevant. Full PCS codes require completion of all seven characters — consult the PCS tables for the applicable fiscal year.

PCS Section	Body System	Root Operation	Clinical Application
0 (Medical & Surgical)	0 (Central Nervous System)	H (Insertion)	00H00MZ — Insertion of neurostimulator lead into brain, open approach (DBS lead placement — subthalamic nucleus [STN] or globus pallidus interna [GPi])
0 (Medical & Surgical)	J (Subcutaneous Tissue)	H (Insertion)	0JH60MZ — Insertion of stimulator generator into chest subcutaneous tissue and fascia (DBS internal pulse generator placement)
0 (Medical & Surgical)	0 (Central Nervous System)	B (Excision)	Pallidotomy or thalamotomy — ablative alternative to DBS; rare in current practice
0 (Medical & Surgical)	0 (Central Nervous System)	W (Revision)	DBS lead revision or IPG replacement (battery change) — revision root operation

---

💊 Coding Scenarios and Examples

---

Scenario 1 — Established Parkinson’s Disease, No Motor Complications (Outpatient Visit)

Clinical Vignette: A 67-year-old male with Parkinson’s disease diagnosed 3 years ago presents for routine neurology follow-up. He is on levodopa/carbidopa 25/100 mg three times daily with a stable, consistent response throughout the day. No dyskinesia, no wearing-off, no OFF episodes. Rest tremor and mild bradykinesia present but well controlled. No cognitive complaints. Physician documents: “Parkinson’s disease without dyskinesia or motor fluctuations, well-controlled.”

CPT Codes (Outpatient/Physician):

• 99214 — Office visit, established patient, moderate MDC

ICD-10-CM:

• G20.A1 — Parkinson’s disease without dyskinesia, without mention of fluctuations (principal — no mandatory etiology/manifestation pairing needed when no dementia)

No Dementia Documented — G20.A1 Stands Alone

When Parkinson’s disease dementia is absent or not documented, G20.A1 is reported as the sole PD code without a mandatory F02.x partner. The “Use additional code” instruction is conditional — F02.x codes are added only when dementia is separately documented.

---

Scenario 2 — Parkinson’s Disease Dementia, Moderate, With Behavioral Disturbance (Inpatient)

Clinical Vignette: A 74-year-old male with 9-year history of Parkinson’s disease is admitted for management of hallucinations and agitation. He has established moderate-severity Parkinson’s disease dementia with behavioral disturbance (visual hallucinations, nighttime agitation). He has no dyskinesia on current levodopa regimen and no wearing-off documented. Physician documents: “Parkinson’s disease without dyskinesia or fluctuations, with moderate-severity dementia and behavioral disturbance.”

Principal Diagnosis:

• G20.A1 — Parkinson’s disease without dyskinesia, without mention of fluctuations (etiology — mandatory principal per etiology/manifestation convention)

Additional Diagnoses:

• F02.B1 — Dementia in other diseases classified elsewhere, moderate severity, with behavioral disturbance (manifestation — mandatory secondary code per “Use additional code” instruction)

MS-DRG Assignment:

• Groups to MDC 01; F02.B1 — verify MCC/CC status for DRG 056 vs. 057 determination

Etiology/Manifestation — G20.A1 Always Sequences First

In any Parkinson’s disease dementia encounter, G20.A1 (or appropriate G20 variant) is the etiology and always sequences first. The F02.x dementia code is the manifestation and always sequences second. This is the same etiology/manifestation convention that governs Alzheimer’s disease dementia coding.

---

Scenario 3 — Parkinson’s Disease, DBS Programming Visit (Outpatient)

Clinical Vignette: A 71-year-old female with Parkinson’s disease without dyskinesia or fluctuations, status post bilateral subthalamic nucleus DBS implantation 6 months ago, presents for routine DBS programming adjustment. Programming session takes 30 minutes.

CPT Codes:

• 99213 — Office visit, established patient, low MDC (separately identifiable E/M); append modifier -25
• 95983 — DBS programming, first 15 minutes
• 95984 — +DBS programming, each additional 15 minutes (×1 for the second 15-minute block)

ICD-10-CM:

• G20.A1 — Parkinson’s disease without dyskinesia, without mention of fluctuations (G20.A1 through G20.B2 all support DBS medical necessity)

Modifier -25 Required on E/M Same DOS as DBS Programming

When a separately identifiable E/M service is performed on the same date as 95983/95984 DBS programming, modifier -25 must be appended to the E/M code — the E/M must be documented as distinct from and beyond the DBS programming check itself.

---

Scenario 4 — Parkinson’s Disease, Aspiration Pneumonia, DRG 056 (Inpatient)

Clinical Vignette: A 78-year-old male with advanced Parkinson’s disease without dyskinesia or fluctuations (G20.A1), severe dementia (F02.C0), and known dysphagia is admitted with aspiration pneumonia. Treated with IV antibiotics, respiratory therapy, and SLP evaluation.

Principal Diagnosis:

• G20.A1 — Parkinson’s disease without dyskinesia, without mention of fluctuations

Additional Diagnoses:

• F02.C0 — Dementia in other diseases, severe, without disturbance (mandatory F02.x pair; severe dementia = MCC)
• J69.0 — Pneumonitis due to inhalation of food and vomit (aspiration pneumonia = MCC)
• R13.19 — Other dysphagia (contributing comorbidity; drives SLP consult, diet modification, aspiration precautions)

MS-DRG Assignment:

• With J69.0 (MCC) and F02.C0 (MCC) → DRG 056 (Degenerative Nervous System Disorders with MCC)

The DRG 056 CDI Story for Parkinson's

This scenario demonstrates the highest-value CDI pathway for Parkinson’s disease inpatient encounters. The combination of G20.A1 + severe dementia (F02.C0) + aspiration pneumonia (J69.0) + dysphagia (R13.19) produces DRG 056 — one of the highest weighted DRGs in MDC 01. Every one of these codes requires explicit physician documentation. Missing any one of them risks falling to the far lower-weighted DRG 057.

---

⚠️ Coding Pitfalls and Tips

	Pitfall or Tip
❌	Do not submit the retired bare G20 code for dates of service on or after October 1, 2023 — it is non-billable and will generate a specificity rejection; always use one of the five G20 subcodes
❌	Do not use G20.A1 when dyskinesia is documented — dyskinesia documented anywhere in the record requires G20.B1 (no fluctuations) or G20.B2 (with fluctuations); using G20.A1 when dyskinesia exists is undercoding
❌	Do not use G20.A1 when wearing-off/OFF episodes are documented — wearing-off requires G20.A2 (no dyskinesia) or G20.B2 (with dyskinesia); missing fluctuations undercodes motor complication severity
❌	Do not use G20.A1 for drug-induced parkinsonism — neuroleptic or other drug-induced parkinsonism is Excludes1 from G20; use G21.11 or G21.19 with the appropriate adverse effect T-code
❌	Do not sequence F02.x as principal — Parkinson’s disease dementia codes (F02.80/F02.Ax/F02.Bx/F02.Cx) are mandatory manifestation codes; G20.A1 always sequences first when both are coded
❌	Do not omit the F02.x code when Parkinson’s dementia is documented — the “Use additional code” instruction is mandatory when dementia is present; G20.A1 without the dementia pair underrepresents the clinical picture and misses HCC 125/126/127 capture
✅	Query for motor complication status at every PD encounter — “Does the patient have dyskinesia? Does the patient experience wearing-off or OFF episodes between doses?” → these answers determine the correct G20 subcode
✅	Query for dementia severity — unspecified severity → F02.80 (HCC 127); mild → F02.A0 (HCC 127); moderate → F02.B0 (HCC 126); severe → F02.C0 (HCC 125) — severity documentation is the highest-impact v28 CDI action
✅	Code dysphagia (R13.19) whenever documented — it drives aspiration precautions, SLP consult coding, and directly affects DRG complexity by establishing clinical context for aspiration-related complications
✅	Code aspiration pneumonia (J69.0) when documented — MCC that drives DRG 056; frequently undercoded in Parkinson’s inpatient encounters
✅	Query for dementia behavioral disturbance type — hallucinations → F02.x2; agitation/aggression → F02.x1; depressed mood → F02.x3; anxiety → F02.x4; selecting the correct 5th character reflects true neuropsychiatric complexity
✅	Verify DBS candidacy code support — G20.A1 through G20.B2 all appear on payer LCD/NCD G20 code ranges supporting DBS medical necessity; ensure the code is current and specificity-appropriate for prior authorization

---

📚 Sources

1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Tabular List — G20.A1; G20.A-B subcategory structure; Use additional code instructions; Etiology/Manifestation Convention (Section I.B.13).

2. Jankovic J. Parkinson’s Disease: Clinical Features and Diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368-376. Cardinal motor features; dyskinesia and fluctuation pathophysiology.

3. Practical Neurology. Parkinson Disease ICD-10-CM Coding. Published March 2026. G20 subcategory structure and proposed future expansions.

4. UASI Solutions. Parkinson’s Disease Tremor vs. Dyskinesia Coding. Published April 2025. G20.A1-G20.B2 clinical distinctions for coder guidance.

5. CMS. 2026 Medicare Advantage CMS-HCC Model v28 — Final Risk Adjustment Coefficients and ICD-10-CM Mappings. HCC 155 (Parkinson’s Disease and Huntington’s Disease).

6. CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 01; DRG 056/057 Degenerative Nervous System Disorders.

7. Boston Scientific. Deep Brain Stimulation 2026 Reimbursement Guide. CPT 95983/95984/61885/61886; ICD-10-CM G20.A1-G20.C supporting medical necessity.

8. AMA. CPT Professional Edition 2026. Neurology subsection; DBS programming codes 95983/95984; Implanted neurostimulator CPT codes.

9. CMS. NCCI Policy Manual for Medicare Services, current version. Chapter on neurology/neurosurgery correct coding principles.